Wang, E. S., Montesinos, P., Minden, M. D., Sibai, H., Lee, J.-H., Heuser, M., Naoe, T., Chou, W.-C., Laribi, K., Esteve, J., Altman, J. K., Havelange, V., Watson, A.-M., Fumagalli, M., Patkowska, E., Hill, J. E., Gill, S. C., Pandya, B. J., Chen, C. and Hasabou, N. (2020) “Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301112.